R. Díaz Beveridge

Long-term results with oral fluoropyrimidines and oxaliplatin-based preoperative chemoradiotherapy in patients with resectable rectal cancer. A single-institution experience

J. Aparicio, S. Roldán, A. Segura, 2012, Clinical and Translational Oncology.

Carcinoma of unknown primary site: development in a single institution of a prognostic model based on clinical and serum variables

J. P. Ponce Lorenzo, Á. Segura Huerta, R. Díaz Beveridge, 2007, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups.

J. Blay, J. Coindre, P. Bruzzi, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Management of advanced pancreatic cancer with gemcitabine plus erlotinib: efficacy and safety results in clinical practice.

J. Aparicio, A. Segura, J. Montalar, 2014, JOP : Journal of the pancreas.

Orbital and myocardial metastases of a primary pulmonary melanotic schwannoma

R. Díaz Beveridge, P. Richart Aznar, M. Corbellas Aparicio, 2010, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[Primary melanoma of the rectum: an infrequent neoplasia with an atypical presentation].

R. Díaz Beveridge, M. Vallalta Morales, J. I. Cervera Miguel, 2005, Clinical and Translational Oncology.

Controversies in the multimodality management of locally advanced rectal cancer

J. Aparicio, G. Bruixola, R. Díaz Beveridge, 2017, Medical Oncology.

Guideline for the diagnosis and treatment of esophageal cancer ( 2016 )

M. Alsina, F. Rivera, V. Arrazubi, 2016 .

Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2.

M. Hidalgo, F. Rivera, A. M. Muñoz Martín, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial

A. Arance, E. Espinosa, C. Montagut, 2021, Nature Communications.

Real-world study on characteristics of advanced melanoma patients with sustained complete response (CR) after elective 1st line anti-programmed death-1 (anti-PD1) monotherapy discontinuation.

S. Ochenduszko, A. Berrocal, M. J. Juan-Fita, 2022, Journal of Clinical Oncology.

Epidemiological pattern and time trends in testicular germ-cell tumors: a single institution 20-year experience.

J. P. Ponce Lorenzo, R. Díaz Beveridge, A. Giménez Ortiz, 2006, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Pancreatic cancer, Radiomics and Artificial Intelligence: A Review

L. Martí-Bonmatí, Á. Alberich-Bayarri, R. Díaz Beveridge, 2022, The British Journal of Radiology.